Genomics

Dataset Information

0

Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer.


ABSTRACT: The IRE1α-XBP1 arm of the unfolded protein response (UPR) has emerged as a central orchestrator of malignant progression and immunosuppression in various cancer types. Yet the role of this pathway in non-small cell lung cancer (NSCLC) has remained largely unexplored. Using an RNA-seq based computational XBP1s detection method applied to TCGA datasets, we uncovered that expression of the IRE1a-generated XBP1s mRNA isoform predicts poor survival in NSCLC patients. Ablation of IRE1a in malignant cells delayed tumor progression and extended survival in an XBP1-dependent fashion in mouse models of NSCLC. This protective effect was accompanied by marked alterations in both lymphoid and myeloid intratumoral cell subsets that elicited durable adaptive anti-cancer immunity. Mechanistically, cancer cell-intrinsic IRE1α activation sustained mPGES-1 expression, enabling production of the immunosuppressive lipid mediator PGE2 in the tumor microenvironment (TME). Accordingly, restoring mPGES-1 expression in IRE1αKO cancer cells rescued normal tumor progression. By identifying the dominant transcriptional networks controlled by IRE1α in mouse lung tumors, we further developed a new gene signature that predicted immune cell infiltration and overall survival in human NSCLC. Hence, our study unveils a key immunoregulatory role for cancer cell-intrinsic IRE1α activation and suggests that targeting this pathway may help enhance anti-tumor immunity in NSCLC.

ORGANISM(S): Mus musculus

PROVIDER: GSE202939 | GEO | 2022/05/13

REPOSITORIES: GEO

Similar Datasets

2021-02-10 | GSE166417 | GEO
2018-10-30 | GSE103864 | GEO
2020-05-16 | GSE131404 | GEO
2009-04-25 | GSE15771 | GEO
2018-10-18 | GSE118430 | GEO
2022-09-30 | GSE205488 | GEO
2021-08-11 | GSE157117 | GEO
2021-08-11 | GSE157116 | GEO
2023-12-30 | GSE163137 | GEO
2019-12-18 | GSE121880 | GEO